ATE352287T1 - Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen - Google Patents

Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen

Info

Publication number
ATE352287T1
ATE352287T1 AT02793140T AT02793140T ATE352287T1 AT E352287 T1 ATE352287 T1 AT E352287T1 AT 02793140 T AT02793140 T AT 02793140T AT 02793140 T AT02793140 T AT 02793140T AT E352287 T1 ATE352287 T1 AT E352287T1
Authority
AT
Austria
Prior art keywords
ibuprofen
weight per
per volume
pharmaceutical compositions
oral administration
Prior art date
Application number
AT02793140T
Other languages
English (en)
Inventor
Redondo Ana Maria Jimenez
Abanades Laura Berges
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Application granted granted Critical
Publication of ATE352287T1 publication Critical patent/ATE352287T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02793140T 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen ATE352287T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102705A ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Publications (1)

Publication Number Publication Date
ATE352287T1 true ATE352287T1 (de) 2007-02-15

Family

ID=8499662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793140T ATE352287T1 (de) 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen

Country Status (6)

Country Link
EP (1) EP1452169B1 (de)
AT (1) ATE352287T1 (de)
AU (1) AU2002358819A1 (de)
DE (1) DE60217903T2 (de)
ES (1) ES2197781B1 (de)
WO (1) WO2003047550A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
CN101616607B (zh) * 2007-02-23 2014-06-04 B.R.A.I.N.生物技术研究与信息网络股份公司 含有至少一种高倍甜味剂(his)的物质组合物的调味方法
DK2139347T3 (da) 2007-02-23 2011-04-18 Brain Biotechnology Res & Information Network Ag Anvendelse af vanddispergerbare carotenoid-nanopartikler som smagsmodulatorer, smagsmodulatorer indeholdende vanddispergerbare carotenoid-nanopartikler og fremgangsmåder til smagsmodulation
DK2142011T3 (da) 2007-02-23 2011-04-18 Brain Biotechnology Res & Information Network Ag Fremgangsmåde til smagsmodulering af stofsammensætninger, der indeholder mindst ét højintensitetssødemiddel (HIS)
DE202008006492U1 (de) 2007-02-23 2008-08-21 Basf Se Verwendung von wasserdispergierbaren Carotinoid-Nanopartikeln als Geschmacksmodulatoren, Geschmacksmodulatoren, enthaltend wasserdispergierbare Carotinoid-Nanopartikel
DE202008006164U1 (de) 2008-03-05 2008-10-02 Basf Se Verwendung eines Polyoxyethylensorbitanfettsäureesters zur Geschmacksmodulation von stofflichen Zusammensetzungen, die mindestens einen High Intensity Sweetener (HIS) enthalten
DE202008006163U1 (de) 2008-03-05 2008-10-02 Basf Se Verwendung einer Salzzubereitung zur Geschmacksmodulation von stofflichen Zusammensetzungen, die mindestens einen High Intensity Sweetener (HIS) enthalten
EP3760205A4 (de) * 2018-02-28 2021-10-27 Sumitomo Dainippon Pharma Co., Ltd. Pharmazeutische zubereitung vom typ einer wässrigen suspension
CN117883379A (zh) * 2021-02-12 2024-04-16 浙江贝灵生物医药有限公司 一种口服碱性溶媒组合物及其制备方法与应用
US20230364172A1 (en) * 2022-05-14 2023-11-16 Syncotrance, LLC Modulation of solubility, palatability, absorption, and bioavailability of mitragyna speciosa-derived compounds for oral and buccal delivery
CN115671046B (zh) * 2022-10-10 2024-04-26 澳美制药(苏州)有限公司 布洛芬混悬滴剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
AU717764B2 (en) * 1996-05-02 2000-03-30 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug

Also Published As

Publication number Publication date
WO2003047550A1 (es) 2003-06-12
ES2197781A1 (es) 2004-01-01
AU2002358819A1 (en) 2003-06-17
DE60217903T2 (de) 2007-11-22
EP1452169A1 (de) 2004-09-01
ES2197781B1 (es) 2005-02-16
EP1452169B1 (de) 2007-01-24
DE60217903D1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
EP1708686A4 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
EA200400432A1 (ru) Производные мочевины
DE60021749D1 (de) Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
PL358103A1 (pl) Hydrofilowe molekularne roztwory dyspersyjne karwedilolu
ATE331525T1 (de) Salzformarme polyallylamine
CY1110264T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ευαισθητα σε ρη συμπολυμερη τυπου μπλοκ και υδροφοβο φαρμακο
EP1291362A4 (de) Komplex aus folsäure und polysacchariden, dessen herstellung sowie diesen komplex als aktiven bestandteil enthaltende pharmazeutische zusammensetzung
ATE352287T1 (de) Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
ATE386725T1 (de) Heterocyclylverbindungen
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0102055D0 (sv) New Compounds
PT992509E (pt) Novos derivados macrolidos
ATE367165T1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
ATE440838T1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UY27373A1 (es) Formulaciones de interferón beta-humano
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
SE0001916D0 (sv) Novel formulation
AR026631A1 (es) ''3-4-dihidroquinazolinas 5,6-disustituidas''
NO20054662L (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties